HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.

AuthorsR McMillan
JournalThe New England journal of medicine (N Engl J Med) Vol. 344 Issue 18 Pg. 1402-3 (May 03 2001) ISSN: 0028-4793 [Print] United States
PMID11336065 (Publication Type: Case Reports, Comment, Letter)
Chemical References
  • Cyclophosphamide
  • Danazol
  • Colchicine
  • Prednisone
Topics
  • Colchicine (therapeutic use)
  • Cyclophosphamide (therapeutic use)
  • Danazol (therapeutic use)
  • Drug Therapy, Combination
  • Fatal Outcome
  • Follow-Up Studies
  • Humans
  • Prednisone (therapeutic use)
  • Purpura, Thrombocytopenic, Idiopathic (drug therapy)
  • Recurrence
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: